Elimination of established tumors with nanodisc-based combination chemoimmunotherapy

Although immune checkpoint blockade has shown initial success for various cancers, only a small subset of patients benefits from this therapy. Some chemotherapeutic drugs have been reported to induce antitumor T cell responses, prompting a number of clinical trials on combination chemoimmunotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Kuai, Rui, Yuan, Wenmin, Son, Sejin, Nam, Jutaek, Xu, Yao, Fan, Yuchen, Schwendeman, Anna, Moon, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906077/
https://www.ncbi.nlm.nih.gov/pubmed/29675465
http://dx.doi.org/10.1126/sciadv.aao1736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906077/
https://www.ncbi.nlm.nih.gov/pubmed/29675465
http://dx.doi.org/10.1126/sciadv.aao1736

Ejemplares similares